Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Challenges in understanding host genetics and severity of community-acquired pneumonia

Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
ERJ Open Research 2021 7: 00745-2020; DOI: 10.1183/23120541.00745-2020
Jordi Solé-Violán
1Intensive Care Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
2CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
15These authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Hernández-Brito
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
15These authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Manuel Valencia-Gallardo
5Dept of Respiratory Diseases, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Estefanía Herrera-Ramos
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Estefanía Herrera-Ramos
Luis Borderías
6Dept of Respiratory Diseases, Hospital San Jorge, Huesca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis Borderías
M. Luisa Briones
7Dept of Respiratory Diseases, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Rajas
8Dept of Respiratory Diseases, Hospital Universitario de la Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Freixinet
9Dept of Thoracic Surgery, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Lorente
10Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoni Payeras
11Dept of Internal Medicine, Hospital Son Llatzer, Palma de Mallorca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Ferreres
12Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nieves Carbonell
12Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nereida González-Quevedo
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús M. González-Martín
13Biostatistics Division, Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesús M. González-Martín
Felipe Rodríguez de Castro
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
5Dept of Respiratory Diseases, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Rodríguez-Gallego
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
14University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Tables

  • TABLE 1

    Genotype data of patients with community-acquired pneumonia (CAP)

    Patients nGenotype frequencies (%)p-value
    OR (95% CI)
    Genotype comparisonsAllele comparisons
    CCCTTTRecessive model: CC versus TC+TTAdditive model
    rs4957796
     CAP96029 (52.7)243 (46.8)688 (49.8)0.5830.510.502
     Control99626 (47.3)276 (53.2)694 (50.2)1.16 (0.68–1.99)0.94 (0.80–1.12)0.94 (0.80–1.12)
     Dead 28 days572 (6.9)11 (4.5)44 (6.4)0.6880.440.446
     Alive 28 days90327 (93.1)232 (95.5)644 (93.6)1.18 (0.27–5.09)0.81 (0.47–1.40)0.81 (0.46–1.41)
     Dead 90 days762 (6.9)15 (6.2)59 (8.6)1.0000.260.262
     Alive 90 days88427 (93.1)228 (93.8)629 (91.4)0.86 (0.20–3.68)0.76 (0.47–1.24)0.75 (0.46–1.24)
     ARDS643 (10.3)15 (6.2)46 (6.7)0.4350.820.814
     No ARDS89626 (89.7)228 (93.8)642 (93.3)1.65 (0.48–5.59)1.06 (0.66–1.70)1.06 (0.65–1.72)
     SS/SSh31314 (48.3)79 (32.5)220 (32.0)0.0680.250.235
     No SS/SSh64715 (51.7)164 (67.5)468 (68.0)1.97 (0.94–4.14)1.16 (0.90–1.50)1.17 (0.90–1.51)
     Sepsis76527 (93.1)192 (79.0)546 (79.4)0.0410.340.338
     No sepsis1952 (6.9)51 (21.0)142 (20.6)3.53 (0.83–15.00)1.16 (0.85–1.58)1.17 (0.85–1.60)
     ICU3389 (31.0)82 (33.7)247 (35.9)0.6330.440.432
     No ICU62220 (69.0)161 (66.3)441 (64.1)0.82 (0.37–1.83)0.90 (0.70–1.17)0.90 (0.69–1.17)
     ICU dead 28 days#441 (11.1)6 (7.3)37 (15.0)1.0000.0930.106
     ICU alive 28 days#2948 (88.9)76 (92.7)210 (85.0)0.81 (0.10–6.81)0.55 (0.26–1.16)0.54 (0.25–1.15)
     ICU dead 90 days#621 (11.1)10 (12.2)51 (20.6)1.0000.0680.076
     ICU alive 90 days#2768 (88.9)72 (87.8)196 (79.4)0.55 (0.07–4.47)0.57 (0.31–1.08)0.57 (0.30–1.07)
    rs62375529
     CAP96023 (45.1)214 (48.2)723 (49.5)0.5640.470.462
     Controls99628 (54.9)230 (51.8)738 (50.5)0.85 (0.49–1.48)0.94 (0.79–1.12)0.93 (0.78–1.12)
     Dead 28 days574 (17.4)8 (3.7)45 (6.2)0.0420.880.874
     Alive 28 days90319 (82.6)206 (96.3)678 (93.8)3.51 (1.15–10.7)1.04 (0.61–1.78)1.05 (0.61–1.80)
     Dead 90 days764 (17.4)11 (5.1)61 (8.4)0.1010.700.696
     Alive 90 days88419 (82.6)203 (94.9)662 (91.6)2.53 (0.84–7.63)0.91 (0.56–1.48)0.91 (0.55–1.49)
     ARDS642 (8.7)13 (6.1)49 (6.8)0.6620.930.929
     No ARDS89621 (91.3)201 (93.9)674 (93.2)1.34 (0.31–5.86)0.98 (0.58–1.54)0.98 (0.58–1.66)
     SS/SSh31314 (60.9)66 (30.8)233 (32.2)0.003¶0.20.189
     No SS/SSh6479 (39.1)148 (69.2)490 (67.8)3.32 (1.42–7.76)1.19 (0.91–1.56)1.20 (0.91–1.58)
     Sepsis76522 (95.7)165 (77.1)578 (79.9)0.0250.770.764
     No sepsis1951 (4.3)49 (22.9)145 (20.1)5.74 (0.77–42.90)1.05 (0.76–1.45)1.05 (0.76–1.46)
     ICU3389 (39.1)68 (31.8)261 (36.1)0.6900.450.439
     No ICU62214 (60.9)146 (68.2)462 (63.9)1.19 (0.51–2.77)0.90 (0.69–1.18)0.90 (0.68–1.18)
     ICU dead 28 days442 (22.2)5 (7.4)37 (14.2)0.3310.460.451
     ICU alive 28 days2247 (77.8)63 (92.6)224 (85.8)1.95 (0.39–9.71)0.77 (0.38–1.56)0.76 (0.36–1.57)
     ICU dead 90 days622 (22.2)8 (11.8)52 (19.9)0.6720.270.260
     ICU alive 90 days2767 (77.8)60 (88.2)209 (80.1)1.28 (0.26–6.32)0.71 (0.38–1.33)0.69 (0.36–1.32)

    Bivariate and multivariate analyses were performed using SPSS (version 15.0; SPSS, Inc., Chicago, IL, USA). The mean±sd age of the patients and controls was 61.8±17.7 and 44.3±19.3 years, respectively; 620 (66%) patients and 435 controls (52%) were male. Genotype distribution of both single-nucleotide polymorphisms did not differ significantly under conditions of Hardy–Weinberg equilibrium in the control group (p=0.444 for rs4957796, p=0.746 for rs62375529). Data are presented as n (%), unless otherwise stated. ARDS: acute respiratory distress syndrome; SS/SSh: severe sepsis/septic shock; ICU: intensive care unit; ICU dead 28/90 days: patients admitted to the ICU who died at 28/90 days; ICU alive 28/90 days: patients admitted to the ICU who survived at 28/90 days #: p-value for the bivariate comparison calculated with the Chi-squared test. ¶: after adjustment for age, sex, comorbidities and admitting hospital, the rs62375529 FER variant remains significantly associated with severe sepsis risk (OR=5.17; 95% CI 1.963–13.68, p=0.001), p-value for the multivariate analysis calculated with binary logistic regression.

    PreviousNext
    Back to top
    Vol 7 Issue 1 Table of Contents
    ERJ Open Research: 7 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Challenges in understanding host genetics and severity of community-acquired pneumonia
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Challenges in understanding host genetics and severity of community-acquired pneumonia
    Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
    ERJ Open Research Jan 2021, 7 (1) 00745-2020; DOI: 10.1183/23120541.00745-2020

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Challenges in understanding host genetics and severity of community-acquired pneumonia
    Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
    ERJ Open Research Jan 2021, 7 (1) 00745-2020; DOI: 10.1183/23120541.00745-2020
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    Subjects

    • Genetics
    • Respiratory infections and tuberculosis
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • rs2070600 SNP regulates AGER splicing and sputum sRAGE
    • Procoagulant microparticles and COVID-19
    • Cancer referral and interventional pulmonology during COVID-19
    Show more Original research letters

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About ERJ Open Research

    • Editorial board
    • Journal information
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Online ISSN: 2312-0541

    Copyright © 2023 by the European Respiratory Society